Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.
Faggiano A, Ramundo V, Dicitore A, Castiglioni S, Borghi MO, Severino R, Ferolla P, Crinò L, Abbruzzese A, Sperlongano P, Caraglia M, Ferone D, Hofland L, Colao A, Vitale G.
Faggiano A, et al. Among authors: castiglioni s.
J Cell Mol Med. 2012 Jul;16(7):1563-72. doi: 10.1111/j.1582-4934.2011.01438.x.
J Cell Mol Med. 2012.
PMID: 21883896
Free PMC article.